Average Co-Inventor Count = 5.80
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The General Hospital Corporation (26 from 2,893 patents)
2. Massachusetts Institute of Technology (15 from 8,373 patents)
3. The Broad Institute, Inc. (13 from 443 patents)
4. Dana-farber-cancer Institute Inc. (8 from 1,209 patents)
5. Harvard College (6 from 2,963 patents)
6. Massachusetts General Hospital Corporation (1 from 83 patents)
7. The General Hospital Corporation D/b/a Massachusetts General Hospital (1 patent)
32 patents:
1. 12419885 - Kinase inhibitors and methods of use thereof
2. 11639325 - Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders
3. 11596691 - Photoswitchable HDAC inhibitors
4. 11572368 - Inhibitors of histone deacetylase
5. RE49240 - Inhibitors of histone deacetylase
6. 11377423 - Inhibitors of histone deacetylase
7. 11180438 - Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders
8. 11084803 - Activators of class I histone deacetylases (HDACs) and uses thereof
9. 11052080 - Kinase inhibitors and methods of use thereof
10. 10828367 - Photoswitchable HDAC inhibitors
11. 10662199 - Inhibitors of histone deacetylase
12. 10172905 - Treatment of protein degradation disorders
13. 10167277 - Activators of class I histone deacetlyases (HDACs) and uses thereof
14. 10137122 - Kinase inhibitors and methods of use thereof
15. 10124035 - DISC-1 pathway activators in the control of neurogenesis